Glivec

Rediff.com » News » Glivec

News for Glivec

Business

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

'Novartis ruling won't affect pharma industry'

Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board, has recently ruled that the......

'US industry reviewing SC decision on Novartis'

The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......

The man behind Glivec hails verdict against Novartis

Even though Novartis and other multinational corporations are upset with the Indian Supreme Court’s decision to reject Novartis’ patent claim on Glivec, the key man behind the popular......

Indian pharma has no incentive to innovate

No one expected, when the first major clinical trial started on Glivec in 2000, that the patients would live much beyond a couple of years.Yet, seven years later, 86 per cent of them were still......

Web results for Glivec

ProfNet Experts Available on Cancer Care, Parkinson's and Brain Disorders

/PRNewswire/ -- Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. If you are interested... ...

http://in.advfn.com/p.php?pid=nmona&article=57067905

The battle for patent protection

(Any opinions expressed here are those of the author and not necessarily of Reuters) The Supreme Court verdict on Glivec brought to an end the... ...

http://blogs.reuters.com/india-expertzone/2013/04/08/the-battle-for-patent-protection/

Indias Solution To Drug Costs Ignore Patents And Control Prices - Except For Home Grown Drugs

In a country where very few people have health insurance, 70% of Indians pay for healthcare expenses out of their own pockets. When it comes to... ...

http://www.mumbainews.net/index.php/sid/213683212/scat/701ee96610c884a6

Glivec and the question of innovation

Incremental improvements of existing products to secure patents are a menace ...

http://www.livemint.com/Opinion/ZdNAcYqLytenU1TRtdJlsN/Glivec-and-the-question-of-innovation.html

Novartis, AstraZeneca, Roche Holding, Pfizer and Gilead Sciences

/PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the... ...

http://in.advfn.com/p.php?pid=nmona&article=57066523

See All

Rediff News

Glivec

News for Glivec

'Judgment will ensure no ever-greening of patents'

'Novartis ruling won't affect pharma industry'

'US industry reviewing SC decision on Novartis'

The man behind Glivec hails verdict against Novartis

Indian pharma has no incentive to innovate

Related Tags

Top Coverage News

Indian Premier League - 2013

Get Ahead: Lakme Fashion 2013

The 1971 War: 40 Years On

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog